Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Frontiers in Oncology|March 29, 2021
Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-AnalysisKe Zhu, Aiqun Xu, Wanli Xia, et al.Molecular and Clinical Oncology|April 29, 2017
Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancerHeng Lin, Shuimei Luo, Lina Li, et al.Apoptosis : an International Journal on Programmed Cell Death|April 18, 2024
LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathwayEnze Wang, Binbin Zhang, Ling Huang, et al.Journal of Cellular Biochemistry|August 18, 2017
Hypoxia-induced microRNA-26b inhibition contributes to hypoxic pulmonary hypertension via CTGFSijing Zhou, Li Sun, Chao Cao, et al.Current Microbiology|December 2, 2024
Characterization of a Putative Lysin from Enterococcus faecalis Phage IME-EFm1 and Determination of its Protective Efficacy in MiceCan Wang, Youhong Guan, Wanrong Wang, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysisZili Wang, Haitao Yang, Shuimei Luo, et al.Briefings in Functional Genomics|December 1, 2021
Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancerHuihui Jiang, Aiqun Xu, Min Li, et al.Frontiers in Cell and Developmental Biology|October 4, 2021
Effect of Methylation Status of lncRNA-MALAT1 and MicroRNA-146a on Pulmonary Function and Expression Level of COX2 in Patients With Chronic Obstructive Pulmonary DiseaseLi Sun, Aiqun Xu, Min Li, et al.Journal of Inflammation Research|August 1, 2022
High Expression of DEPDC1B Predicts Poor Prognosis in Lung AdenocarcinomaPulin Li, Xiaojuan Chen, Sijing Zhou, et al.Cancer Cell International|August 15, 2021
Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysisHuihui Jiang, Aiqun Xu, Wanli Xia, et al.Pageof 7